CME Group stock gets fresh signal from director share sale
Published on 11/04/2026 at 16:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSInsider sale adds a new signal
- Director Howard Siegel sold 2,000 CME Group shares in a November 2 transaction.
- He retained 19,873 shares after the sale.
- CME Group's October average daily volume reached a record 30 million contracts.
CME Group stock faces a fresh governance signal after Director Howard Siegel sold 2,000 shares on Monday, November 2, for USD 606,000, according to InsiderTrades. The transaction was completed at an average price of USD 303, and Siegel retained 19,873 shares.
What changed for investors
The sale reduces Siegel's position by 9.14%, but the source also shows that he continued to hold a substantial stake. A single insider transaction does not establish a change in CME Group's operating outlook, so investors may weigh it against the exchange operator's recent trading indicators.
CME Group reported record October average daily volume of 30 million contracts on Tuesday, November 3. The figure was 15% above October 2025, with interest-rate and Treasury activity leading gains across the derivatives franchise.
Rates average daily volume increased 28% to 14.8 million contracts, while U.S. Treasury futures and options reached 9.2 million contracts, up 48%. International average daily volume rose 9% to 9 million contracts, according to the latest company activity report.
Current trading context
CME Group stock traded at 271.70 euros on Lang & Schwarz at 16:35 CET on Wednesday, November 4, 2026.
Investors can follow the real-time quote of CME Group stock.
CME Group Inc.
- ISIN: US12572Q1058
- Ticker: CME
- Lang & Schwarz quote: EUR 271.70 at 16:35 CET on Wednesday, November 4, 2026
- October average daily volume: 30 million contracts
- Year-over-year volume change: 15% increase
The broader U.S. market remains covered in current S&P 500 market reports.
More news and analyses are available on CME Group stock.
